| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cost of Revenue | $37K | -94.6% |
| R&D Expense | $403K | +6.6% |
| SG&A Expense | $2.0M | +20.5% |
| Operating Income | $442K | +273.3% |
| Interest Expense | $732K | -19.5% |
| Net Income | -$922K | -107.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $912K | +116.4% |
| Inventory | $485K | -57.8% |
| Current Assets | $3.1M | -16.2% |
| Total Assets | $5.8M | -26.8% |
| Current Liabilities | $1.1M | +1.2% |
| Stockholders' Equity | $607K | -62.5% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.3M | +103.4% |
| Investing Cash Flow | -$952K | -17.4% |
| Financing Cash Flow | -$577K | -232.3% |